Novel Dual Incretin Receptor Agonists in the Spectrum of Metabolic Diseases with a Focus on Tirzepatide: Real Game-Changers or Great Expectations? A Narrative Review.

Liarakos, Alexandros Leonidas; Koliaki, Chrysi

Liarakos, Alexandros Leonidas; Koliaki, Chrysi.

Liarakos AL; Centre for Diabetes and Endocrinology, Royal Berkshire NHS Foundation Trust, Reading RG1 5AN, UK.
Koliaki C; First Propaedeutic Department of Internal Medicine and Diabetes Center, Laiko General Hospital, Medical Faculty, National Kapodistrian University of Athens, 11527 Athens, Greece.

Biomedicines ; 11(7)2023 Jul 01.

Article en En | MEDLINE | ID: mdl-37509514

Palabras clave

dual incretin receptor agonists; glucagon-like peptide 1; glucose-dependent insulinotropic polypeptide; non-alcoholic fatty liver disease; obesity; tirzepatide; twincretins; type 2 diabetes mellitus

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Año: 2023 Tipo del documento: Article